TY - JOUR T1 - Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection JF - medRxiv DO - 10.1101/2021.06.01.21257759 SP - 2021.06.01.21257759 AU - Chansavath Phetsouphanh AU - David Darley AU - Anette Howe AU - C. Mee Ling Munier AU - Sheila K Patel AU - Jenifer A Juno AU - Louise M Burrell AU - Stephen J Kent AU - Gregory J Dore AU - Anthony D Kelleher AU - Gail Matthews Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/06/03/2021.06.01.21257759.abstract N2 - A proportion of patients surviving acute COVID-19 infection develop post-COVID syndrome (long COVID) encompassing physical and neuropsychiatric symptoms lasting longer than 12 weeks. Here we studied a prospective cohort of individuals with long COVID (the ADAPT study) compared to age/gender matched subjects without long COVID, healthy donors and individuals infected with other non-SARS CoV2 human coronaviruses (the ADAPT-C study). We found an elevated diffuse serum inflammatory cytokine profile in symptomatic long COVID subjects that was maintained at 8 months post-infection and was not observed in asymptomatic COVID-19 survivors. This inflammatory profile consisted of 15 cytokines that positively correlated; revealing an apparent diffuse, potentially coordinated, low level up regulation of a spectrum of immune and inflammatory mediators. In addition, we found an absence of subsets of un-activated naŃ—ve T and B cells in peripheral blood of long COVID subjects, that did not reconstitute over time. In contrast, individual serum cytokines from the interferon I and III classes, T cell activation markers and plasma ACE2, while elevated in the serum of people previously infected with SARS-CoV-2 were not further elevated in subjects with long COVID symptoms. This work defines immunological parameters associated with long COVID and suggests future opportunities to prevention and treatment.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialACTRN12620000554965Funding StatementWe appreciate grant support from the St Vincents Clinic Foundation - the Curran Foundation, the Rapid Response Research Fund (UNSW) - the Medical Research Futures Fund (Australia) - NHMRC programme grant APP 1055214 (LMB) - Medical Research Future Fund award GNT 1175865 - - Austin Medical Research Foundation Grant - the Victorian Government - MRFF Award (2005544) - NHMRC program grant (1149990) - NHMRC Fellowships 1136322 and 1123673Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:- The ADAPT study was approved by the St Vincents Hospital Research Ethics Committee (2020/ETH00964) and is a registered trial (ACTRN12620000554965) - ADAPT-C sub study was approved by the same committee (2020/ETH01429) - All data were stored using REDCap electronic data capture tools - Unexposed healthy donors were recruited through St Vincents Hospital and was approved by St Vincents Hospital Research Ethics Committee (HREC/13/SVH/145) - The University of Melbourne unexposed donors were approved by Medicine and Dentistry HESC-Study ID 2056689. All participants gave written informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSource data files will be uploaded upon submission to intended journal ER -